Access 2.8M+ Filings Sign Up Free
Elanix Biotechnologies AG Logo

Elanix Biotechnologies AG | ELN - Profile, Filings, Stock Info & Investor Relations Data

Elanix Biotechnologies AG | ELN
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Germany
Founded
1994
Elanix Biotechnologies AG (ELN)

Company Profile

Website
Investor Relations

About Elanix Biotechnologies AG

Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services.

The company was founded in 2012 as a spin-off from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells.
The Company is headquartered in Epalinges, Switzerland with offices in Hamburg and listed on the Frankfurt stock exchange under the symbol ELN.

Market Presence

Europe

Headquarters

Hanauer Landstrasse 291
60314, Frankfurt am Main
Germany

Elanix Biotechnologies AG (ELN)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Elanix Biotechnologies AG (ELN)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Elanix Biotechnologies AG (ELN)
Stock & Investor Information

ISINs

DE000A0WMJQ4

LEI

391200SYNFFL0NPAJK90

Designated Sponsor

mwb fairtrade Wertpapierhandelbank AG

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology